Search clinical trials for: SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
Total 783 results
-
Alexion Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, United Kingdom, France, Korea, Republic of, Poland, Netherlands, Japan, Belgium, Greece, Australia, Austria, Brazil, Canada, China, Czechia, Israel, Italy, Russian Federation
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, Russian Federation, France, Korea, Republic of, Poland, Israel, Netherlands, Japan, Belgium, Greece, Switzerland, Australia, Austria, Brazil, Canada, China, Czechia, Italy, United Kingdom
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAmyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)United States
-
Assistance Publique - Hôpitaux de ParisCompletedChronic Renal Failure With Uremic NephropathyFrance
-
University of UlmCentre Hospitalier de Lens (Co-Sponsor)Active, not recruitingWaldenström's MacroglobulinemiaGermany
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Laryngeal Cancer | Oral Cancer | Carcinoma, Squamous | Pharyngeal CancerUnited States
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
Air Force Military Medical University, ChinaNot yet recruitingImmunoglobulin Light-chain Amyloidosis
-
Beijing Chao Yang HospitalPeking University People's HospitalUnknownExtramedullary PlasmacytomaChina
-
Augusta UniversityJanssen Scientific Affairs, LLCNot yet recruitingMultiple Myeloma | Renal FailureUnited States
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
Seoul National University HospitalConsortium for Improving Survival of LymphomaCompletedMantle Cell LymphomaKorea, Republic of
-
Antengene CorporationActive, not recruiting
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Spectrum Health HospitalsMillennium Pharmaceuticals, Inc.CompletedHematological MalignancyUnited States
-
Universitätsklinikum Hamburg-EppendorfGemeinsamer Bundesausschuss (G-BA); Staburo GmbHRecruiting
-
Janssen-Cilag International NVCompletedMultiple MyelomaFrance, Poland, Belgium, Germany, Israel, Portugal, Turkey, Finland, Sweden, Netherlands, Norway
-
Institute of Hematology & Blood Diseases Hospital...TerminatedAcquired Pure Red Cell AplasiaChina
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Samsung Medical CenterCompletedRelapsed and/or Refractory Cutaneous T-cell LymphomaKorea, Republic of
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompleted
-
Sun Yat-sen UniversityUnknown
-
Sparrow Regional Cancer CenterUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
SanofiCompleted
-
La Jolla Pharmaceutical CompanyTerminatedMultiple MyelomaUnited States
-
Sun Yat-sen UniversityFudan University; West China Hospital; Peking University Cancer Hospital & Institute and other collaboratorsUnknownMantle Cell Lymphoma RecurrentChina
-
Mayo ClinicCompletedPrimary Systemic AmyloidosisUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)UnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
Grupo de Estudos Multicentricos em Onco-HematologiaCompletedMultiple Myeloma | Effects of Chemotherapy
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma
-
Eli Lilly and CompanyCompleted
-
European Myeloma NetworkJanssen PharmaceuticaActive, not recruitingLight Chain (AL) Amyloidosis, Stage 3BNetherlands, Greece, France, Italy
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
Chonnam National University HospitalUnknownMultiple MyelomaKorea, Republic of
-
Peking Union Medical College HospitalRecruitingIdiopathic Multicentric Castleman's DiseaseChina
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation; Janssen-Cilag Ltd.UnknownMultiple MyelomaAustralia
-
Novartis PharmaceuticalsCompletedRenal Insufficiency | Multiple MyelomaUnited Kingdom, Spain, United States
-
Meletios A. DimopoulosEuropean Myeloma NetworkCompletedWaldenstrom's MacroglobulinemiaSpain, Greece, Netherlands
-
European Myeloma NetworkUniversitaire Ziekenhuizen KU Leuven; University of Roma La Sapienza; Hospital... and other collaboratorsCompletedWaldenstroms MacroglobulinemiaGreece
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple Myeloma | Non-Hodgkin's LymphomaIsrael, Italy, Poland, South Africa, United Kingdom
-
Medical University of ViennaUnknownLymphoma, Mantle-CellAustria
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study GroupActive, not recruiting